FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912278480> ?p ?o ?g. }

• W2912278480 endingPage "1792" @default.
• W2912278480 startingPage "1781" @default.
• W2912278480 abstract "SHP2 is a nonreceptor protein tyrosine phosphatase within the mitogen-activated protein kinase (MAPK) pathway controlling cell growth, differentiation, and oncogenic transformation. SHP2 also participates in the programed cell death pathway (PD-1/PD-L1) governing immune surveillance. Small-molecule inhibition of SHP2 has been widely investigated, including in our previous reports describing SHP099 (2), which binds to a tunnel-like allosteric binding site. To broaden our approach to allosteric inhibition of SHP2, we conducted additional hit finding, evaluation, and structure-based scaffold morphing. These studies, reported here in the first of two papers, led to the identification of multiple 5,6-fused bicyclic scaffolds that bind to the same allosteric tunnel as 2. We demonstrate the structural diversity permitted by the tunnel pharmacophore and culminated in the identification of pyrazolopyrimidinones (e.g., SHP389, 1) that modulate MAPK signaling in vivo. These studies also served as the basis for further scaffold morphing and optimization, detailed in the following manuscript." @default.
• W2912278480 created "2019-02-21" @default.
• W2912278480 creator A5003676033 @default.
• W2912278480 creator A5005557504 @default.
• W2912278480 creator A5006143818 @default.
• W2912278480 creator A5006563534 @default.
• W2912278480 creator A5007836616 @default.
• W2912278480 creator A5010220817 @default.
• W2912278480 creator A5013010788 @default.
• W2912278480 creator A5013736647 @default.
• W2912278480 creator A5031186608 @default.
• W2912278480 creator A5034804463 @default.
• W2912278480 creator A5037699704 @default.
• W2912278480 creator A5040245567 @default.
• W2912278480 creator A5041672891 @default.
• W2912278480 creator A5041704183 @default.
• W2912278480 creator A5042278912 @default.
• W2912278480 creator A5042448056 @default.
• W2912278480 creator A5045239767 @default.
• W2912278480 creator A5045357554 @default.
• W2912278480 creator A5046110894 @default.
• W2912278480 creator A5046885729 @default.
• W2912278480 creator A5046941126 @default.
• W2912278480 creator A5060985276 @default.
• W2912278480 creator A5065585746 @default.
• W2912278480 creator A5065690853 @default.
• W2912278480 creator A5079336375 @default.
• W2912278480 creator A5079565181 @default.
• W2912278480 date "2019-01-28" @default.
• W2912278480 modified "2023-10-03" @default.
• W2912278480 title "Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors" @default.
• W2912278480 cites W1489827117 @default.
• W2912278480 cites W1982486689 @default.
• W2912278480 cites W2016205588 @default.
• W2912278480 cites W2023090301 @default.
• W2912278480 cites W2058398046 @default.
• W2912278480 cites W2059338259 @default.
• W2912278480 cites W2061122212 @default.
• W2912278480 cites W2082448876 @default.
• W2912278480 cites W2093762625 @default.
• W2912278480 cites W2094548766 @default.
• W2912278480 cites W2130207101 @default.
• W2912278480 cites W2130526419 @default.
• W2912278480 cites W2154923100 @default.
• W2912278480 cites W2160834915 @default.
• W2912278480 cites W2254051095 @default.
• W2912278480 cites W2468923062 @default.
• W2912278480 cites W2475259576 @default.
• W2912278480 cites W2495127614 @default.
• W2912278480 cites W2592133876 @default.
• W2912278480 cites W2781625157 @default.
• W2912278480 cites W2789632821 @default.
• W2912278480 cites W2790214250 @default.
• W2912278480 cites W2791533519 @default.
• W2912278480 cites W2792103163 @default.
• W2912278480 cites W2793191892 @default.
• W2912278480 cites W2804804971 @default.
• W2912278480 cites W2804957989 @default.
• W2912278480 cites W2811095506 @default.
• W2912278480 cites W2887730046 @default.
• W2912278480 cites W2898146177 @default.
• W2912278480 cites W2898440791 @default.
• W2912278480 cites W2913920462 @default.
• W2912278480 doi "https://doi.org/10.1021/acs.jmedchem.8b01725" @default.
• W2912278480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30688462" @default.
• W2912278480 hasPublicationYear "2019" @default.
• W2912278480 type Work @default.
• W2912278480 sameAs 2912278480 @default.
• W2912278480 citedByCount "50" @default.
• W2912278480 countsByYear W29122784802019 @default.
• W2912278480 countsByYear W29122784802020 @default.
• W2912278480 countsByYear W29122784802021 @default.
• W2912278480 countsByYear W29122784802022 @default.
• W2912278480 countsByYear W29122784802023 @default.
• W2912278480 crossrefType "journal-article" @default.
• W2912278480 hasAuthorship W2912278480A5003676033 @default.
• W2912278480 hasAuthorship W2912278480A5005557504 @default.
• W2912278480 hasAuthorship W2912278480A5006143818 @default.
• W2912278480 hasAuthorship W2912278480A5006563534 @default.
• W2912278480 hasAuthorship W2912278480A5007836616 @default.
• W2912278480 hasAuthorship W2912278480A5010220817 @default.
• W2912278480 hasAuthorship W2912278480A5013010788 @default.
• W2912278480 hasAuthorship W2912278480A5013736647 @default.
• W2912278480 hasAuthorship W2912278480A5031186608 @default.
• W2912278480 hasAuthorship W2912278480A5034804463 @default.
• W2912278480 hasAuthorship W2912278480A5037699704 @default.
• W2912278480 hasAuthorship W2912278480A5040245567 @default.
• W2912278480 hasAuthorship W2912278480A5041672891 @default.
• W2912278480 hasAuthorship W2912278480A5041704183 @default.
• W2912278480 hasAuthorship W2912278480A5042278912 @default.
• W2912278480 hasAuthorship W2912278480A5042448056 @default.
• W2912278480 hasAuthorship W2912278480A5045239767 @default.
• W2912278480 hasAuthorship W2912278480A5045357554 @default.
• W2912278480 hasAuthorship W2912278480A5046110894 @default.
• W2912278480 hasAuthorship W2912278480A5046885729 @default.
• W2912278480 hasAuthorship W2912278480A5046941126 @default.
• W2912278480 hasAuthorship W2912278480A5060985276 @default.
• W2912278480 hasAuthorship W2912278480A5065585746 @default.

• next